Australian Clinical Labs Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was AUD 337.27 million compared to AUD 360.31 million a year ago. Revenue was AUD 337.82 million compared to AUD 366.5 million a year ago.

Net income was AUD 4.95 million compared to AUD 25.42 million a year ago. Basic earnings per share from continuing operations was AUD 0.0247 compared to AUD 0.1267 a year ago. Diluted earnings per share from continuing operations was AUD 0.0246 compared to AUD 0.1265 a year ago.